Beta Drugs Financials

NSE: BETA

₹1,849.70

up-down-arrow ₹-127.10 (-6.43%)

As on 29-Oct-2026IST

Market cap

info icon

₹2,057 Cr

Revenue (TTM)

info icon

₹444 Cr

P/E Ratio

info icon

39.6

P/B Ratio

info icon

4.7

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
444.27
384.83
362.36
295.71
227.11
183.84
Total Income
452.81
396.01
368.79
297.07
227.87
184.59
Total Expenditure
351.96
309.15
287.75
235.72
173.99
141.14
EBITDA
92.31
75.68
74.61
60.00
53.13
42.70
Depreciation
18.14
17.15
12.51
9.78
10.41
7.25
EBIT
74.17
58.53
62.09
50.22
42.72
35.44
Interest
12.58
15.31
6.99
2.82
2.41
1.90
Other Income
8.54
11.18
6.44
1.36
0.75
0.76
Exceptional Items
--
--
-4.57
--
--
--
Profit before Tax
70.12
54.39
56.97
48.75
41.06
34.30
Provision for Tax
16.79
12.91
14.55
12.32
10.34
9.47
Profit after Tax
53.34
41.48
42.42
36.44
30.72
24.83
Minority Interest
-1.42
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
51.92
41.66
42.42
36.44
30.72
24.83

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
437.70
244.77
197.10
157.12
122.88
92.34
Minority Interest
-1.42
--
--
--
--
--
Non-Current Liabilities
37.20
140.37
134.58
10.90
11.32
15.86
Current Liabilities
144.38
116.06
113.39
94.40
69.70
54.85
Total Liabilities
656.31
503.72
446.89
263.83
205.11
163.73

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
232.30
158.12
114.02
74.82
69.54
60.21
Current Assets
379.62
343.08
331.04
187.60
134.37
102.83
Total Assets
656.31
503.72
446.89
263.83
205.11
163.73
Total Debt*
--
147.81
138.06
14.71
20.33
20.60
Net Current Assets
235.24
227.02
217.66
93.20
64.67
47.99
Contingent Liabilities
--
--
--
1.55
1.51
1.77

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
37.29
36.14
30.93
23.38
29.63
Cash Flow from Investing Activities
--
-51.39
-35.72
-13.97
-19.07
-21.75
Cash from Financing Activities
--
-8.07
117.97
-7.49
-2.47
-0.97
Net Cash Inflow / Outflow
--
-22.18
118.39
9.47
1.84
6.90

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
48.30
41.10
42.02
36.10
30.43
24.60
Cash EPS (₹) info
46.68
57.84
54.42
45.79
40.74
31.78
Adjusted Book Value (₹) info
393.57
241.46
195.25
155.65
121.73
91.48
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
36.78
35.81
32.17
24.32
30.82
Free Cash Flow per Share (₹) info
--
-21.54
-0.94
21.87
3.35
3.00

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
19.16
25.23
32.74
33.94
36.38
ROE (%) info
15.21
18.78
23.95
26.03
28.55
30.85
ROA (%) info
16.25
8.77
11.99
15.63
16.74
17.53
EBIT Margin (%) info
16.69
15.21
17.14
16.98
18.81
19.28
Net Margin (%) info
11.78
10.48
11.50
12.27
13.48
13.45
Cash Profit Margin (%) info
--
15.24
15.16
15.63
18.11
17.45

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
15.20
6.20
22.54
30.21
23.54
58.31
EBIT Growth (%) info
19.55
-5.74
23.65
17.55
20.52
98.35
Net Profit Growth (%) info
14.62
-2.21
16.42
18.62
23.73
111.76
EPS Growth (%) info
16.28
-2.20
16.41
18.62
23.73
111.76
Book Value Growth (%) info
--
24.19
25.45
27.86
33.07
34.58

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
39.62
28.94
45.35
31.00
19.62
21.90
Price / Book Value info
4.70
4.93
9.76
7.55
4.90
5.89
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
19.85
14.14
23.62
19.10
11.21
12.59
Close Price (₹) info
2,053.00
1,189.30
1,905.50
1,175.00
597.10
538.57
High Price (₹) info
2,807.90
2,000.00
2,215.24
1,519.05
975.62
661.90
Low Price (₹) info
990.10
990.10
1,047.62
578.38
520.05
113.33
Market Cap (₹ Cr) info
2,057.10
1,205.58
1,923.53
1,186.11
602.74
543.66

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
0.06
0.60
0.70
0.09
0.17
0.22
Short term debt to equity ratio info
--
0.03
0.03
0.03
0.07
0.05
Current Ratio info
2.63
2.96
2.92
1.99
1.93
1.88
Quick Ratio info
2.06
2.32
2.39
1.55
1.49
1.47
Interest Coverage info
6.57
4.55
9.15
18.29
18.00
19.06

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
37.69
30.96
28.31
26.80
27.62
24.58
Asset Turnover info
1.35
0.81
1.02
1.27
1.24
1.30
Receivable days info
--
105.14
91.57
87.61
86.71
78.48
Inventory Days info
--
63.66
55.19
49.64
42.67
38.24
Payable days info
--
161.92
139.01
121.55
124.66
101.32
Cash Conversion Cycle info
--
6.88
7.75
15.70
4.72
15.40
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds